Steroid-induced ocular hypertension with loteprednol etabonate 0.2%—A case report

Jaanus, 2008, Anti-inflammatory drugs Friedlander, 1997, A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. The loteprednol etabonate giant papillary conjunctivitis study group 1, Am J Ophthalmol, 123, 455, 10.1016/S0002-9394(14)70171-0 Dell, 1997, A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivits. The Loteprednol Etabonate Giant Papillary Conjunctivitis Study Group, Am J Ophthalmol, 123, 791, 10.1016/S0002-9394(14)71128-6 Bodor, 1992, A comparison of intraocular pressure elevating activity of loteprednol etabonate and dexamethasone in rabbits, Curr Eye Res, 11, 525, 10.3109/02713689209001808 Ilyas, 2004, Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis, Eye Contact Lens, 30, 10, 10.1097/01.ICL.0000092071.82938.46 Shulman, 1999, A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis, Ophthalmology, 106, 362, 10.1016/S0161-6420(99)90077-5 Novack, 1998, Change in intraocular pressure during chronic use of loteprednol etabonate, J Glaucoma, 7, 266, 10.1097/00061198-199808000-00009 Suzuki, 1997, Mutations in the TIGR gene in familial primary open-angle glaucoma in Japan, Am J Hum Genet, 61, 1204, 10.1086/301612 Polansky, 1997, Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product, Ophthalmologica, 211, 126, 10.1159/000310780 Rozsa, 2006, Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure, Mol Vis, 12, 125 Abelson, 1998, The conjunctival provocation test model of ocular allergy: utility for assessment of an ocular corticosteroid, loteprednol etabonate, J Ocular Pharmacology and Therapeutics, 14, 533, 10.1089/jop.1998.14.533 Bartlett, 1993, Intraocular pressure response to loteprednol etabonate in known steroid responders, J Ocular Pharmacology, 9, 157, 10.1089/jop.1993.9.157